China Education Resources Inc. Soccer Program Update
Jan 22, 2018 14:01 pm UTC| Business
VANCOUVER, British Columbia, Jan. 22, 2018 -- China Education Resources, Inc. ("CER") (TSX-V:CHN) (OTC:CHNUF), an ed-tech company with leading technology of intelligent system and contents to provide online/offline...
Hearsay Adds Client Engagement Tools to Unlock New Levels of Sales, Compliance Productivity
Jan 22, 2018 14:01 pm UTC| Business
San Francisco, California, Jan. 22, 2018 -- Hearsay, provider of the Hearsay Advisor Cloud for the financial services industry, today announced several new tools that leverage multi-channel client engagement data to...
Hearsay Adds Client Engagement Tools to Unlock New Levels of Sales, Compliance Productivity
Jan 22, 2018 14:01 pm UTC| Business
San Francisco, California, Jan. 22, 2018 -- Hearsay, provider of the Hearsay Advisor Cloud for the financial services industry, today announced several new tools that leverage multi-channel client engagement data to...
CordovaCann Enters Colorado Market
Jan 22, 2018 14:01 pm UTC| Business
TORONTO, Jan. 22, 2018 -- CordovaCann Corp. (OTCQB:LVRLF) (“CordovaCann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Cordova CO Holdings, LLC, has entered into a license agreement (the...
Jan 22, 2018 14:01 pm UTC| Business
COVINGTON, La., Jan. 22, 2018 -- LLOG Exploration Company, L.L.C. (“LLOG”) today announced that development drilling operations have begun at the Buckskin project in the deepwater Gulf of Mexico. Buckskin is located on...
American Heart Association announces Triangle Life is Why sponsorship with Chiesi USA
Jan 22, 2018 14:01 pm UTC| Business
RALEIGH, N.C., Jan. 22, 2018 -- The American Heart Association (AHA) proudly announces Chiesi (key-A-zee), a Cary-based specialty pharmaceutical company, as the first Life is Why sponsor in the Triangle. ...
Jan 22, 2018 14:01 pm UTC| Business
SAN DIEGO, Jan. 22, 2018 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces completion of patient enrollment in SCLERADEC II (NCT02558543), a randomized, double-blind, placebo-controlled, parallel group, multi-center...